MetaCap

Matinas Biopharma Insider Trades

NYSE: MTNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.87+0.04 (+1.41%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Matinas Biopharma insider activity

Over the last 12 months, Matinas Biopharma insiders reported 3 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows STERN ADAM K (10% Owner) reporting a transaction in 344,710 shares at $0.35 on Jul 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MTNB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

MTNB insider transactions

Matinas Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Jul 10, 2026STERN ADAM K10% OwnerOption exercise630,335$220.62KForm 4
Jul 10, 2026STERN ADAM K10% OwnerOption exercise344,710$120.65KForm 4
Oct 31, 2025STERN ADAM K10% OwnerOption exercise92,100$59.37KForm 4
Jun 22, 2022CONRAD HERBERT JDirectorGift1,358,122—Form 4
Jun 22, 2022CONRAD HERBERT JDirectorGift1,358,122—Form 4
Dec 31, 2021WIKLER MATTHEWDirectorAward7,859—Form 4
Aug 4, 2021CONRAD HERBERT JDirectorGift494,622—Form 4
Aug 4, 2021CONRAD HERBERT JDirectorGift494,622—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related